Search Results - "FOSS, Joseph F."

Refine Results
  1. 1

    An overview of the cannabinoid type 2 receptor system and its therapeutic potential by Bie, Bihua, Wu, Jiang, Foss, Joseph F, Naguib, Mohamed

    Published in Current opinion in anaesthesiology (01-08-2018)
    “…This narrative review summarizes recent insights into the role of the cannabinoid type 2 (CB2) receptor as potential therapeutic target in neuropathic pain and…”
    Get full text
    Journal Article
  2. 2

    Activation of mGluR1 Mediates C1q-Dependent Microglial Phagocytosis of Glutamatergic Synapses in Alzheimer’s Rodent Models by Bie, Bihua, Wu, Jiang, Foss, Joseph F., Naguib, Mohamed

    Published in Molecular neurobiology (01-08-2019)
    “…Microglia and complements appear to be involved in the synaptic and cognitive deficits in Alzheimer’s disease (AD), though the mechanisms remain elusive. In…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2 expression in a transgenic mouse model of Alzheimer's disease by Wu, Jiang, Hocevar, Mark, Foss, Joseph F., Bie, Bihua, Naguib, Mohamed

    Published in European journal of pharmacology (15-09-2017)
    “…Alzheimer's disease (AD) is a neurodegenerative disorder characterized by neuroinflammation, extensive deposits of amyloid-β aggregates, and loss of memory and…”
    Get full text
    Journal Article
  5. 5

    Amyloid Fibril–Induced Astrocytic Glutamate Transporter Disruption Contributes to Complement C1q-Mediated Microglial Pruning of Glutamatergic Synapses by Wu, Jiang, Bie, Bihua, Foss, Joseph F., Naguib, Mohamed

    Published in Molecular neurobiology (01-05-2020)
    “…The complement C1q plays a critical role in microglial phagocytosis of glutamatergic synapses and in the pathogenesis of neuroinflammation in Alzheimer’s…”
    Get full text
    Journal Article
  6. 6

    Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial by Yuan, Chun-Su, Wei, Gang, Foss, Joseph F, O'Connor, Michael, Karrison, Theodore, Osinski, Joachim

    “…Methylnaltrexone, the first peripheral opioid receptor antagonist, has the potential to prevent or reverse opioid-induced peripherally mediated side effects…”
    Get more information
    Journal Article
  7. 7

    Amyloid fibrils induce dysfunction of hippocampal glutamatergic silent synapses by Bie, Bihua, Wu, Jiang, Foss, Joseph F., Naguib, Mohamed

    Published in Hippocampus (01-08-2018)
    “…Silent glutamatergic synapses lacking functional AMPA (α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazoleproprionate) receptors exist in several brain regions including…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Peripherally Acting Mu-Opioid Receptor Antagonists and Postoperative Ileus: Mechanisms of Action and Clinical Applicability by Viscusi, Eugene R., Gan, Tong J., Leslie, John B., Foss, Joseph F., Talon, Mark D., Du, Wei, Owens, Gay

    Published in Anesthesia and analgesia (01-06-2009)
    “…Postoperative ileus (POI), a transient cessation of coordinated bowel function after surgery, is an important health care problem. The etiology of POI is…”
    Get full text
    Journal Article
  10. 10

    A Review of the Potential Role of Methylnaltrexone in Opioid Bowel Dysfunction by Foss, Joseph F

    Published in The American journal of surgery (01-11-2001)
    “…Opioids are widely used analgesics in patients with advanced cancer. However, their effectiveness for pain relief is often limited by the most frequently…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Methylnaltrexone for Reversal of Constipation Due to Chronic Methadone Use: A Randomized Controlled Trial by Yuan, Chun-Su, Foss, Joseph F, O'Connor, Michael, Osinski, Joachim, Karrison, Theodore, Moss, Jonathan, Roizen, Michael F

    “…CONTEXT Constipation is the most common chronic adverse effect of opioid pain medications in patients who require long-term opioid administration, such as…”
    Get full text
    Journal Article
  12. 12

    Are Peripheral Opioid Antagonists the Solution to Opioid Side Effects? by Bates, John J., Foss, Joseph F., Murphy, Damian B.

    Published in Anesthesia and analgesia (01-01-2004)
    “…Opioid medication is the mainstay of therapy for severe acute and chronic pain. Unfortunately, the side effects of these medications can affect patient comfort…”
    Get full text
    Journal Article
  13. 13

    Development and use of methylnaltrexone, a peripherally acting opioid antagonist, to treat side effects related to opioid use by Yuan, Chun-Su, Foss, Joseph F., Williams, Wade A., Moss, Jonathan

    Published in Drug development research (01-09-2009)
    “…Opioid medications are used extensively as potent analgesics for treating moderate to severe pain. Although opioids offer reliable pain relief, their use is…”
    Get full text
    Journal Article
  14. 14

    Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial by Yuan, C S, Foss, J F, O'Connor, M, Toledano, A, Roizen, M F, Moss, J

    Published in Clinical pharmacology and therapeutics (01-04-1996)
    “…Methylnaltrexone is a quaternary opioid antagonist with limited ability to cross the blood-brain barrier and the potential to antagonize the peripherally…”
    Get more information
    Journal Article
  15. 15

    The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time by Yuan, Chun‐Su, Foss, Joseph F., Osinski, Joachim, Toledano, Alicia, Roizen, Michael F., Moss, Jonathan

    Published in Clinical pharmacology and therapeutics (01-04-1997)
    “…Methylnaltrexone is a quaternary opioid antagonist with limited ability to cross the blood‐brain barrier that has the potential to antagonize the peripherally…”
    Get full text
    Journal Article
  16. 16

    Effects of Low-Dose Morphine on Gastric Emptying in Healthy Volunteers by Yuan, Chun-Su, Foss, Joseph F., O'Connor, Michael, Roizen, Michael F., Moss, Jonathan

    Published in Journal of clinical pharmacology (01-11-1998)
    “…Appropriate preoperative pain therapy for patients undergoing surgery may be withheld due to the fear that opioids will inhibit gastric emptying and increase…”
    Get full text
    Journal Article
  17. 17

    Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine by Yuan, Chun-Su, Foss, Joseph F, O'Connor, Michael, Osinski, Joachim, Roizen, Michael F, Moss, Jonathan

    Published in Drug and alcohol dependence (01-10-1998)
    “…Opioid compounds are commonly used analgesics. After opioid administration, troublesome subjective effects, such as dysphoria, dizziness, nausea, and pruritus,…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20